The new era in cancer research

被引:241
作者
Varmus, Harold [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
10.1126/science.1126758
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
For many years, discoveries about the genetic determinants of cancer appeared to be having only minor effects on efforts to control the disease in the clinic. Following advances made over the past decade, however, a description of cancer in molecular terms seems increasingly likely to improve the ways in which human cancers are detected, classified, monitored, and treated. Achieving the medical promise of this new era in cancer research will require a deeper understanding of the biology of cancer and imaginative application of new knowledge in the clinic, as well as political, social, and cultural changes.
引用
收藏
页码:1162 / 1165
页数:6
相关论文
共 38 条
[21]   Cysteine cathepsins in human cancer [J].
Jedeszko, C ;
Sloane, BF .
BIOLOGICAL CHEMISTRY, 2004, 385 (11) :1017-1027
[22]   Cancer statistics, 2005 [J].
Jemal, A ;
Murray, T ;
Ward, E ;
Samuels, A ;
Tiwari, RC ;
Ghafoor, A ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30
[23]   Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells [J].
Li, Y ;
Welm, B ;
Podsypanina, K ;
Huang, SX ;
Chamorro, M ;
Zhang, XM ;
Rowlands, T ;
Egeblad, M ;
Cowin, P ;
Werb, Z ;
Tan, LK ;
Rosen, JM ;
Varmus, HE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) :15853-15858
[24]  
Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022
[25]   Tumour microenvironment - Opinion - Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy [J].
Overall, CM ;
Kleifeld, O .
NATURE REVIEWS CANCER, 2006, 6 (03) :227-239
[26]   KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib [J].
Pao, W ;
Wang, TY ;
Riely, GJ ;
Miller, VA ;
Pan, QL ;
Ladanyi, M ;
Zakowski, MF ;
Heelan, RT ;
Kris, MG ;
Varmus, HE .
PLOS MEDICINE, 2005, 2 (01) :57-61
[27]   Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: Current knowledge and future directions [J].
Pao, W ;
Miller, VA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) :2556-2568
[28]  
PEARCE J, 2006, NY TIMES 0316, pA25
[29]   Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer [J].
Piccart-Gebhart, MJ ;
Procter, M ;
Leyland-Jones, B ;
Goldhirsch, A ;
Untch, M ;
Smith, I ;
Gianni, L ;
Baselga, J ;
Bell, R ;
Jackisch, C ;
Cameron, D ;
Dowsett, M ;
Barrios, CH ;
Steger, G ;
Huang, CS ;
Andersson, M ;
Inbar, M ;
Lichinitser, M ;
Láng, I ;
Nitz, U ;
Iwata, H ;
Thomssen, C ;
Lohrisch, C ;
Suter, TM ;
Ruschoff, J ;
Süto, T ;
Greatorex, V ;
Ward, C ;
Straehle, C ;
McFadden, E ;
Dolci, MS ;
Gelber, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16) :1659-1672
[30]   Stem cells, cancer, and cancer stem cells [J].
Reya, T ;
Morrison, SJ ;
Clarke, MF ;
Weissman, IL .
NATURE, 2001, 414 (6859) :105-111